| Aabo, Gitte (Leo Pharma 201511 CEO) |
Chief Executive Officer (CEO) |
Leo Pharma (Group) |
Denmark |
| Abdollahian, Neil (Boundless Bio 202108– CBO before Cidara Therapeutics + Clarity Point Partners + Trius Therapeutics) |
Chief Business Officer (CBO) |
Boundless Bio Inc. |
United States (USA) |
| Abdullah, Hesham (GSK 202310 SVP Global Head Oncology RnD) |
Research & Development Manager |
GSK (Group) |
United Kingdom (GB) |
| Aburatani, Yoshihiro (RIKEN 201910 President of RIKEN Innovation Co Ltd) |
President/Director/Head Business Group/Unit/Division |
RIKEN Research Cluster for Innovation (JP) |
Japan |
| Acciarito, Tony (Thermo Fisher 201609 VP + General Manager Thermo Fisher South Korea) |
General Manager (management) |
Thermo Fisher (Group) |
Korea, Republic of |
| Adam, Maxine (United Kingdom (govt) 202310 Head of Business Growth at Innovate UK) |
Business Development Manager / Strategy Manager |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Adams, Tom (Pairwise 202308 CEO + Co-Founder before Monsanto 201708 VP Biotechnology) |
Chief Executive Officer (CEO) |
Pairwise (Group) |
United States (USA) |
| Adomakah, Nicholas (Novartis 202301 Sandoz Anti-infectives Global Medical Lead) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Agnus, Jean-Baptiste (JB) (JSR Corp 202404– CBO at KBI Biopharma before AGC Biologics + Ajinomoto Bio-Pharma + Novasep) |
Chief Business Officer (CBO) |
JSR Corporation (Group) |
United States (USA) |
| Agrawal, Bhuwnesh (Sysmex 202004– Managing Director (CEO) of Sysmex Inostics GmbH before Eppendorf + Vela Dx + Roche) |
Managing Director |
Sysmex (Group) |
Germany |
| Aisher, Patrick (Kinled 202104 at Kinled Austria) |
Investment Manager |
Kinled (Group) |
Austria |
| Akatsuka, Hiroyuki (Osaka (govt) 202210 Associate Director of Life Sciences Industry Division) |
Administrative Officer (personnel) |
Osaka (govt region) |
Japan |
| Akira, Shizuko (Osaka (govt) 202210 President of OSaka Bio Headquarters) |
Cluster Manager |
Osaka (govt region) |
Japan |
| Al-Olayan, Abdurahman (Dammam Valley 202209 CEO) |
Chief Executive Officer (CEO) |
Saudi Arabia (govt) |
Saudi Arabia |
| Alberici, Luca (Asahi Glass 202403 General Manager + Managing Director at AGC Biologics Italy before MolMed 201903 CBO) |
Chief Business Officer (CBO) |
Asahi Glass (AGC) (Group) |
Italy |
| Allmaier, Günter (Vienna University of Techology 201104 Professor) |
Professor |
Vienna University of Technology (TU Wien) |
Austria |
| Almeida, José E. (Covidien 201112 CEO) |
Chief Executive Officer (CEO) |
Covidien (Group) |
Ireland, Republic of |
| Altorfer, Michael (Swiss Biotech Association 201811 CEO before Polyphor + Roche + Ciba-Geigy + Sandoz + UBS Warburg) |
Chief Executive Officer (CEO) |
Swiss Biotech Association (SBA) |
Switzerland |
| Amar, Frédéric (Esperite 201801 CEO) |
Chief Executive Officer (CEO) |
Esperite (Group) |
Netherlands |
| An, Hyun Joo (Chungnam National Univ 201112 Professor at GRAST) |
Professor |
Chungnam National University |
Korea, Republic of |
| Anand, Ravi (Newron Pharmaceuticals 201103 CMO) |
Chief Medical Officer (CMO) |
Newron (Group) |
Italy |
| Ananth, Radhika (Accel 202101 Vice President) |
Investment Manager |
Accel (Group) |
India |
| Anderson (formerly Broder), Elizabeth (LianBio 202103 VP Communications + IR before MeiraGTx) |
Public Relations Manager / Investor Relations Manager |
LianBio |
|
| Anderson, Joe (Sofinnova Partners 2022 Partner before Arix Bioscience + Abingworth) |
Investment Manager |
Sofinnova (Group) |
France |
| Anson, John (Oxford Gene Technology 200601–202203 before Amersham Biosciences/GE Healthcare RETIRED 4/22) |
Chief Executive Officer (CEO) |
Sysmex (Group) |
United Kingdom (GB) |
| Aoki, Yoshikazu (Asahi Kasei 202203 President of Asahi Kasei Pharma) |
President/Director/Head Business Group/Unit/Division |
Asahi Kasei (Group) |
Japan |
| Apte, Arun (Premier Biosoft 201210 CEO) |
Chief Executive Officer (CEO) |
Premier Biosoft (Group) |
United States (USA) |
| Apter, Jason (Sigma-Aldrich 201504 VP + Managing Director Asia Pacific) |
Managing Director |
Merck (DE) (Group) |
Singapore |
| Aras, Rahul (Juventas Therapeutics 201811 CEO) |
Chief Executive Officer (CEO) |
Juventas Therapeutics Inc. |
United States (USA) |
| Archinard, Philippe (Institu Mérieux 202101– EVP Technological Innovation + Scientific Partnerships before Transgene) |
Chief Executive Officer (CEO) |
Mérieux (Group) |
France |
| Arendt, Christopher (Chris) (Takeda 201905 Head Oncology Drug Discovery Unit) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
Japan |
| Arif, Arsalan (Endpoints 2014 Founder before Fierce Markets Group Publisher Life Sciences) |
Journalist |
Nikkei (Group) |
United States (USA) |
| Arnold, Jonathan (Qiagen 202409 VP + Head of Translation Science + Precision Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Netherlands |
| Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Asanuma, Sakae (Otsuka 201705 President of Taiho Ventures) |
President/Director/Head Business Group/Unit/Division |
Otsuka (Group) |
United States (USA) |
| Atkins, David (Congenica 201801– CEO before Synevo + Leica Biosystems + JnJ/Ortho Clinical Diagnostics) |
Chief Executive Officer (CEO) |
Congenica (Group) |
United Kingdom (GB) |
| Atnip, David (Prometheus Fund (Shanghai) 201705 Director) |
President/Director/Head Business Group/Unit/Division |
Prometheus Fund (Shanghai) |
China |
| Au, Alan (GT Healthcare Capital Partners 201612 Managing Partner + Founder) |
Managing Partner |
GT Healthcare Capital Partners L.P. |
China |
| Audivert, Sergi (AB-Biotics 201211 CEO + co-founder) |
Chief Executive Officer (CEO) |
AB-Biotics S.A. |
Spain (España) |
| Azadbakht, Hojjat (Ainostics 202202 CEO) |
Chief Executive Officer (CEO) |
Ainostics Ltd. |
United Kingdom (GB) |
| Azoulay, Sam (Roivant 201910 CMO at Roivant Pharma) |
Chief Medical Officer (CMO) |
Roivant (Group) |
United Kingdom (GB) |
| Azzam, Fouad (Life Sciences Partners 201509 Partner at US Office of LSP) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
United States (USA) |
| Baertschi, Gabriel (Grünenthal 201610– CEO before President AstraZeneca Japan + Managing Director AstraZeneca GmbH) |
Chief Executive Officer (CEO) |
Grünenthal (Group) |
Germany |
| Baeten, Kristoff (Monkeys not Donkeys 202204 CEO + Founder) |
Chief Executive Officer (CEO) |
QbD Group (Quality by Design) (Group) |
Belgium |
| Baiker, Wolfgang (Adrenomed 202101–202203 CEO + Venture Partner at Wellington Partners before Boehringer Ingelheim LEFT) |
Chief Executive Officer (CEO) |
Adrenomed AG |
Germany |
| Bailey, Andrew C. (Andy) (ViruSure 201211 Managing Director, Operations) |
Managing Director |
ViruSure GmbH |
Austria |
| Bains, Peter (MiNA Therapeutics 202009– CBO before Sosei Heptares + Biocon/Syngene International + GSK) |
Chief Business Officer (CBO) |
MiNA Therapeutics Ltd. |
United Kingdom (GB) |
| Balster, Kay G. (High-Tech Gründerfonds 201202 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Ban, Toshikazu (Fujifilm 201907 Corporate VP of Fujifilm Corp) |
President/Director/Head Business Group/Unit/Division |
Fujifilm (Group) |
Japan |
| Bao, Jun (Biotheus 202311 Business Development) |
Business Development Manager / Strategy Manager |
Biotheus Inc. (CN) |
China |
| Barathan, Vijay (UnitedHealth 202005 at Optum Ventures) |
n. a. |
UnitedHealth (Group) |
United States (USA) |
| Baratte, Sophie (Cellnovo 201602 CEO) |
Chief Executive Officer (CEO) |
Cellnovo (Group) |
France |
| Bardroff, Christiane (Rentschler 202212– COO joined 2/22 before Teva Ulm + Roche) |
Chief Operating Officer (COO) |
Rentschler (Group) |
Germany |
| Barlach, Johann (Variolytics 202212 CFO) |
Chief Financial Officer (CFO) |
Variolytics GmbH |
Germany |
| Barner, Andreas (Boehringer) |
Board member |
Boehringer Ingelheim (Group) |
Germany |
| Barnes, Matt (Sosei 202310 President of Heptares Therapeutics + Head of UK RnD) |
President/Director/Head Business Group/Unit/Division |
Nxera Pharma (Group) |
United Kingdom (GB) |
| Barnes, Thomas M. (Orna Therapeutics 202102 CEO) |
Chief Executive Officer (CEO) |
Orna Therapeutics Inc. |
United States (USA) |
| Barr, Sharon (AstraZeneca 202311 EVP BioPharmaceuticals RnD) |
Research & Development Manager |
AstraZeneca (Group) |
United Kingdom (GB) |
| Barrett, Mark (Applied Process Company 202006 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Applied Process Company (APC) (Group) |
Ireland, Republic of |
| Barron, Hal (GSK 201801– CSO before Alphabet (Calicio) + Roche/Genentech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GSK (Group) |
United Kingdom (GB) |
| Barsan, Valentin (Vali) (SoftBank 202201 at SoftBank Investment Adivsers) |
Investment Manager |
SoftBank (Group) |
|
| Barth, Jörg (Boehringer Ingelheim 201507 Corporate SVP Therapy Area Head Oncology) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Germany |
| Bastian, Helge (Thermo Fisher 201406 General Manager Synthetic Biology before Indivumed + Sigma-Aldrich + SGS + Qiagen) |
Managing Director |
Thermo Fisher (Group) |
United States (USA) |
| Batra, Udit (Waters 202009– CEO before Merck Life Sciences + Merck Millipore + Novartis + JnJ + McKinsey) |
Chief Executive Officer (CEO) |
Waters (Group) |
United States (USA) |
| Bauer, Ariel (SGS 202401 Group VP Investor Relations, Communications + Sustainability) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| Bauer, Michael (Quantro Therapeutics 202305– CEO before Cellestia Biotech CEO) |
Chief Executive Officer (CEO) |
Quantro Therapeutics GmbH |
Austria |
| Baum, Charles M. (Mirati Therapeutics 201211– CEO before Pfizer + Schering-Plough) |
Chief Executive Officer (CEO) |
|
|
| Baumann, Werner (Bayer 201605– CEO before Chief Strategy + Portfolio Officer + CFO joined Bayer1988) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Bedborough, Katie (Oxford VR 202002 CFO + COO) |
Chief Financial Officer (CFO) |
BehaVR (Group) |
United Kingdom (GB) |
| Bédier, Jérôme (Flash Therapeutics 202307– CEO before Novasep + Easy-Cell) |
Chief Executive Officer (CEO) |
Flash Therapeutics SAS |
France |
| Been, Kees (Kynexis 202311– CEO formerly EnVivo 200506– CEO before Bionaut CEO + Biogen) |
Chief Executive Officer (CEO) |
Kynexis (Group) |
Netherlands |
| Behar, Greg (Recipharm 202401– CEO before CEO of Nestlé Health Science before Novartis + Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
Recipharm (Group) |
Sweden |
| Belichard, Pierre (Enterome 201203 CEO) |
Chief Executive Officer (CEO) |
Enterome S.A. |
France |
| Belldegrun, Arie (Allogene 201806 Executive Chairman before Kite Pharma CEO) |
Board member, executive |
Gilead Sciences (Group) |
United States (USA) |
| Belli, Brita (Insilico Medicine 202211 PR) |
Public Relations Manager / Investor Relations Manager |
Insilico Medicine (Group) |
China |
| Benedict, Nicholas (Vaderis Therapeutics 202208 CEO + Co-Foudner formerly Allecra Therapeutics) |
Chief Executive Officer (CEO) |
Vaderis Therapeutics AG |
Switzerland |
| Benefiel, Monty (Agilent 201506 Division General Manager Mass Spec before 201302 VP for gas phase systems) |
President/Director/Head Business Group/Unit/Division |
Agilent (Group) |
United States (USA) |
| Benioff, Marc (Salesforce 202012 CEO) |
Chief Executive Officer (CEO) |
Salesforce.com Inc. (NYSE: CRM) |
United States (USA) |
| Bennison, Maya (Nxera Pharma 202409 Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Nxera Pharma (Group) |
United Kingdom (GB) |
| Berg, Niclas (Zeria 202307 Lead Corporate Communications at Tillotts Pharma) |
Public Relations Manager / Investor Relations Manager |
Zeria (Group) |
Switzerland |
| Berg, Susan (Agilent 201311–201410 Global Public Relations Life Sciences/Chemical Analysis Group LEFT 10/14) |
public relations / investor relations |
Agilent (Group) |
United States (USA) |
| Berka, Klaus (Analytik Jena 200702 Chairman Executive Board) |
Chief Executive Officer (CEO) |
Endress+Hauser (Group) |
Germany |
| Bermingham, Nessan (Khosla Ventures 202206 Partner before Intellia Therapeutics 201411– CEO + Co-founder) |
Chief Executive Officer (CEO) |
Khosla Ventures |
United States (USA) |
| Bernard, Thierry (Qiagen 201502– SVP Molecular Dx business area before bioMérieux Corp VP Commcercial Operations) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Netherlands |
| Berthet, Pascale (TreeFrog 202002– Chief Business Development Officer before Fujifilm Cellular Dynamics + Artelis) |
Business Development Manager / Strategy Manager |
TreeFrog Therapeutics (Group) |
France |
| Bertozzi, Carlo (InCephalo 202407 CEO + Co-Founder formerly G7 Therapeutics 201508 CEO) |
Chief Executive Officer (CEO) |
InCephalo AG |
Switzerland |
| Bertrand, Claude (Servier 202310 VP of RnD + CSO before Ipsen + AstraZeneca + Pfizer + Roche + Ciba-Geigy) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Servier (Group) |
France |
| Beyer, Mike (Sam Brown 201609) |
Public Relations Manager / Investor Relations Manager |
Sam Brown Inc. |
United States (USA) |
| Bhagchandani, KK (ACD/Labs 201510 Senior Director-Asia & Pacific Business joined 2003) |
Business Development Manager / Strategy Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
India |
| Bhatnagar, Vivek (Peak Scientific 201508 General Manager India) |
Regional manager |
Peak Scientific (Group) |
India |
| Bianchi, Christophe (Takeda 201412 President Global Oncology Business Unit) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
United States (USA) |
| Bielefeld-Sévigny, Martina (PerkinElmer 200401– VP drug discovery + research reagents before DSM Biologics) |
General Manager (management) |
PerkinElmer (Group) |
United States (USA) |
| Bigois, Mathieu (Ponthieu Partners 201702 Founder + European Venture Partner of ABG) |
Partner (venture partner) |
Ponthieu Partners (FR) |
Switzerland |
| Bilenberg, Kenneth (Fujifilm 202408 COO of Fujifilm Diosynth Biotechnologies) |
Chief Operating Officer (COO) |
Fujifilm (Group) |
United Kingdom (GB) |
| Bindseil, Missy (JSR Corporation 201706 Media Contact at JSR Life Sciences) |
Public Relations Manager / Investor Relations Manager |
JSR Corporation (Group) |
Japan |
| Bing, Chen (AstraZeneca 202211 Managing Director of AZ-CICC Healthcare Investment Fund) |
Managing Director |
AstraZeneca (Group) |
|
| Bintou Sagnang, Fatou (United Arab Emirates (govt) 202106 Partner at Mubadala Capital Ventures) |
Partner (venture partner) |
United Arab Emirates (govt) |
United Arab Emirates (UAE) |
| Birner, Hubert (TVM 200502–200809–) |
General Partner (venture partner) |
TVM (Group) |
Germany |
| Bisgaard, Peter (Nan Fung 202108 Managing Director of NFLS + Pivotal Life Sciences before Novo) |
Managing Director |
Nan Fung (Group) |
China |
| Blanchard, Kerry (Everest Medicines 202208 CEO) |
Chief Executive Officer (CEO) |
Everest Medicines (Group) |
China |
![[LSA] Life-Sciences-Asia.com - The Asia Life Sciences Web Portal](/images/basics/lsa-life-sciences-asia-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
